Tyagi Sanjay, Singh Sandeep, Mukhopadhyay Saibal, Kaul Upkar A
Department of Cardiology, GB Pant Hospital and Maulana Azad Medical College, New Delhi, India.
Am Heart J. 2003 Nov;146(5):920-8. doi: 10.1016/S0002-8703(03)00434-4.
Balloon angioplasty for native coarctation of the aorta (CoA) in adults, though promising, is sometimes limited by significant residual gradient (>20 mm Hg). Few studies available have reported on use of balloon-expandable stents in such a situation. We evaluated the use of self- and balloon-expandable stents in patients with suboptimal response to balloon angioplasty (BA).
Twenty-one hypertensive patients (age, 18 to 61 years; mean, 28.6 +/- 11.2 years) with native CoA and in whom results of BA were suboptimal (ie, residual peak systolic gradient [PSG] >20 mm Hg) underwent stent implantation. Balloon-expandable Palmaz stents were implanted in 5 patients (group A) and self-expandable nitinol aortic stents in the remaining 16 patients (group B).
In group A, PSG decreased from 62.8 +/- 10.6 (53 to 80) mm Hg to 28.1 +/- 6.3 (22 to 39) mm Hg after BA. Systolic gradient further decreased to 8.3 +/- 3.9 (2 to 16) mm Hg (P <.001) after implantation of the balloon-expandable Palmaz stent. In group B, PSG decreased from 70.2 +/- 24.6 (40 to 110) mm Hg to 28.4 +/- 9.8 (22 to 42) mm Hg after BA and further reduced to 9.0 +/- 5.5 (4 to 16) mm Hg (P <.001). One of these patients had a nitinol self-expandable stent implanted after a Palmaz stent embolized immediately after deployment. Nitinol stents were easier to deploy and conformed better to aortic anatomy compared with balloon-expandable stents. In group A, the diameter of the coarcted segment increased from 3.8 +/- 0.8 mm to 13.3 +/- 0.8 mm (P <.001) after stent implantation and in group B it increased from 4.5 +/- 1.1 mm to 14.1 +/- 2.1 mm (P <.001). There was no significant difference between the two groups in the PSG and diameter of the coarcted segment before and after stent implantation. With the exception of one case, in which a Palmaz stent embolized, there was no other complication in our series. On follow-up of 12 to 71 months (mean, 40.7 +/- 5.8 months) all the implanted stents remained in their original position and none showed evidence of fracture. Improvement in hypertension was seen in 20 of 21(95.2%) of the patients. On recatheterization and angiography 1.2 +/- 0.6 years after implantation in 19 patients, one patient showed an increase in PSG to 27 mm Hg across the nitinol stent and underwent successful redilation. No increase in gradient was seen in other patients. Beneficial late remodeling was seen in 10 of 14(71.4%) of patients restudied after implantation of self-expandable stent. None of the patients showed aneurysm formation.
Stent implantation is safe and effective in improving suboptimal results after BA for CoA. Self-expandable stents were easier to implant, adapted better to the wall of the aorta, and in most patients had similar efficacy in reducing coarctation as balloon-expandable stents.
成人主动脉缩窄(CoA)的球囊血管成形术虽前景可期,但有时会受显著残余压差(>20 mmHg)限制。鲜有研究报道在这种情况下使用球囊可扩张支架。我们评估了自膨式和球囊可扩张支架在球囊血管成形术(BA)效果欠佳患者中的应用。
21例患有先天性CoA的高血压患者(年龄18至61岁,平均28.6±11.2岁),其BA效果欠佳(即残余收缩期峰值压差[PSG]>20 mmHg),接受了支架植入术。5例患者(A组)植入了球囊可扩张的帕尔马兹支架,其余16例患者(B组)植入了自膨式镍钛诺主动脉支架。
A组中,BA后PSG从62.8±10.6(53至80)mmHg降至28.1±6.3(22至39)mmHg。植入球囊可扩张的帕尔马兹支架后,收缩期压差进一步降至8.3±3.9(2至16)mmHg(P<.001)。B组中,BA后PSG从70.2±24.6(40至110)mmHg降至28.4±9.8(22至42)mmHg,并进一步降至9.0±5.5(4至16)mmHg(P<.001)。其中1例患者在帕尔马兹支架植入后立即栓塞,随后植入了镍钛诺自膨式支架。与球囊可扩张支架相比,镍钛诺支架更易于植入,且与主动脉解剖结构的贴合度更好。A组中,植入支架后缩窄段直径从3.8±0.8 mm增加至13.3±0.8 mm(P<.001),B组中从4.5±1.1 mm增加至14.1±2.1 mm(P<.001)。两组在植入支架前后的PSG和缩窄段直径方面无显著差异。除1例帕尔马兹支架栓塞的病例外本系列无其他并发症。在12至共71个月(平均40.7±5.8个月)的随访中,所有植入的支架均保持在原位,且均未显示出断裂迹象。21例患者中有20例(95.2%)高血压情况得到改善。在植入后1.2±0.6年对19例患者进行再次导管插入术和血管造影检查时,1例患者镍钛诺支架处的PSG升至27 mmHg,并成功进行了再次扩张。其他患者未观察到压差增加。在植入自膨式支架后接受复查的14例患者中有10例(71.4%)出现了有益的晚期重塑。所有患者均未出现动脉瘤形成。
支架植入术对于改善CoA患者BA效果欠佳的情况是安全有效的。自膨式支架更易于植入,与主动脉壁的贴合度更好,且在大多数患者中,其在减轻缩窄方面的疗效与球囊可扩张支架相似。